Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Fidia Spa ( (IT:FDA) ) just unveiled an update.
Fidia has completed a key step in its financing plan with Global Growth Holding Limited (GGHL), issuing and having fully subscribed a tranche of 50 reserved convertible bonds with attached warrants for a nominal €500,000, alongside 1,250,000 new warrants exercisable over 60 months at an adjusted price of €0.20 per share. On the same day, GGHL requested and obtained the full conversion of these bonds at €0.10 per share, resulting in the issue of 5,000,000 new Fidia shares admitted directly to trading, bringing the company’s share capital to €9,847,761.90 and total shares outstanding to 30,298,485; with this transaction the €4 million POC convertible bond program and its related capital increase are now fully subscribed and converted, strengthening Fidia’s equity base and potentially diluting existing shareholders while supporting its capital structure for future operations.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.15 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is among the world’s leading manufacturers of high‑performance integrated milling systems, numerical controls and CAM software for complex shapes, serving primarily the automotive mould-making and aerospace sectors. With over 40 years of experience and around 135 employees, the group offers end‑to‑end solutions that cover the entire milling process, from programming to finished product, and supports customers worldwide.
Average Trading Volume: 861,916
Technical Sentiment Signal: Strong Sell
Current Market Cap: €2.59M
Learn more about FDA stock on TipRanks’ Stock Analysis page.